Cargando…
β-Cell death is decreased in women with gestational diabetes mellitus
BACKGROUND: Gestational diabetes mellitus (GDM) affects approximately 7–17 % of all pregnancies and has been recognized as a significant risk factor to neonatal and maternal health. Postpartum, GDM significantly increases the likelihood of developing type 2 diabetes (T2D). While it is well establish...
Autores principales: | Kenna, Lauren A., Olsen, John A., Spelios, Michael G., Radin, Michael S., Akirav, Eitan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997764/ https://www.ncbi.nlm.nih.gov/pubmed/27563355 http://dx.doi.org/10.1186/s13098-016-0175-z |
Ejemplares similares
-
Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes
por: Olsen, John A., et al.
Publicado: (2016) -
In Vitro Formation of β Cell Pseudoislets Using Islet-Derived Endothelial Cells
por: Spelios, Michael G., et al.
Publicado: (2013) -
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
por: Olsen, John A., et al.
Publicado: (2016) -
β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008) -
Immune Therapy and β-Cell Death in Type 1 Diabetes
por: Lebastchi, Jasmin, et al.
Publicado: (2013)